Wehrens and colleagues reported RyR2 mutations which decrease the affinity of RyR2 with calstabin2 in patients with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) [7]. Here, RYR2 is linked to catecholaminergic polymorphic ventricular tachycardia.